FI64798C - Foerfarande foer framstaellning av nya terapeutiskt anvaendbara polypeptider - Google Patents
Foerfarande foer framstaellning av nya terapeutiskt anvaendbara polypeptider Download PDFInfo
- Publication number
- FI64798C FI64798C FI782641A FI782641A FI64798C FI 64798 C FI64798 C FI 64798C FI 782641 A FI782641 A FI 782641A FI 782641 A FI782641 A FI 782641A FI 64798 C FI64798 C FI 64798C
- Authority
- FI
- Finland
- Prior art keywords
- formula
- ala
- gly
- preparation
- hcl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- 230000001225 therapeutic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical group C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 10
- 229920001184 polypeptide Polymers 0.000 claims description 9
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- 150000001414 amino alcohols Chemical group 0.000 claims description 4
- 125000006239 protecting group Chemical group 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 11
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- QCZJFMXMDLPIAN-VKHMYHEASA-N (3s)-3-amino-4-hydroxybutanamide Chemical compound OC[C@@H](N)CC(N)=O QCZJFMXMDLPIAN-VKHMYHEASA-N 0.000 description 3
- IPWKGIFRRBGCJO-IMJSIDKUSA-N Ala-Ser Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](CO)C([O-])=O IPWKGIFRRBGCJO-IMJSIDKUSA-N 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 229940125723 sedative agent Drugs 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical group C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 1
- CXISPYVYMQWFLE-VKHMYHEASA-N Ala-Gly Chemical compound C[C@H]([NH3+])C(=O)NCC([O-])=O CXISPYVYMQWFLE-VKHMYHEASA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- JQJPBYFTQAANLE-UHFFFAOYSA-N Butyl nitrite Chemical compound CCCCON=O JQJPBYFTQAANLE-UHFFFAOYSA-N 0.000 description 1
- UWHSNCLYKMZXIV-DFWYDOINSA-N Cl.N[C@@H](CC(N)=O)CO Chemical compound Cl.N[C@@H](CC(N)=O)CO UWHSNCLYKMZXIV-DFWYDOINSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 150000008575 L-amino acids Chemical class 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- CZCIKBSVHDNIDH-NSHDSACASA-N N(alpha)-methyl-L-tryptophan Chemical group C1=CC=C2C(C[C@H]([NH2+]C)C([O-])=O)=CNC2=C1 CZCIKBSVHDNIDH-NSHDSACASA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- -1 asparagine diol Chemical class 0.000 description 1
- 125000000613 asparagine group Chemical group N[C@@H](CC(N)=O)C(=O)* 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003874 central nervous system depressant Substances 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- QTBSBXVTEAMEQO-DYCDLGHISA-N deuterio acetate Chemical compound [2H]OC(C)=O QTBSBXVTEAMEQO-DYCDLGHISA-N 0.000 description 1
- BYHXBBOSJKPUJL-BYPYZUCNSA-N dimethyl (2s)-2-aminobutanedioate Chemical group COC(=O)C[C@H](N)C(=O)OC BYHXBBOSJKPUJL-BYPYZUCNSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60P—VEHICLES ADAPTED FOR LOAD TRANSPORTATION OR TO TRANSPORT, TO CARRY, OR TO COMPRISE SPECIAL LOADS OR OBJECTS
- B60P1/00—Vehicles predominantly for transporting loads and modified to facilitate loading, consolidating the load, or unloading
- B60P1/006—Vehicles predominantly for transporting loads and modified to facilitate loading, consolidating the load, or unloading charge and discharge with pusher plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B60—VEHICLES IN GENERAL
- B60P—VEHICLES ADAPTED FOR LOAD TRANSPORTATION OR TO TRANSPORT, TO CARRY, OR TO COMPRISE SPECIAL LOADS OR OBJECTS
- B60P3/00—Vehicles adapted to transport, to carry or to comprise special loads or objects
- B60P3/06—Vehicles adapted to transport, to carry or to comprise special loads or objects for carrying vehicles
- B60P3/07—Vehicles adapted to transport, to carry or to comprise special loads or objects for carrying vehicles for carrying road vehicles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Mechanical Engineering (AREA)
- Transportation (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1093977 | 1977-09-07 | ||
| CH1093977 | 1977-09-07 | ||
| CH1405877 | 1977-11-17 | ||
| CH1405877 | 1977-11-17 | ||
| CH546878 | 1978-05-19 | ||
| CH546878 | 1978-05-19 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI782641A FI782641A (fi) | 1979-03-08 |
| FI64798B FI64798B (fi) | 1983-09-30 |
| FI64798C true FI64798C (fi) | 1984-01-10 |
Family
ID=27175220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI782641A FI64798C (fi) | 1977-09-07 | 1978-08-29 | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara polypeptider |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US4187295A (fr) |
| EP (1) | EP0001061B1 (fr) |
| JP (1) | JPS5448758A (fr) |
| AT (1) | AT372075B (fr) |
| CA (1) | CA1118768A (fr) |
| DE (1) | DE2860579D1 (fr) |
| DK (1) | DK381978A (fr) |
| ES (1) | ES473071A1 (fr) |
| FI (1) | FI64798C (fr) |
| IE (1) | IE47341B1 (fr) |
| IL (1) | IL55507A (fr) |
| IT (1) | IT1099493B (fr) |
| NZ (1) | NZ188345A (fr) |
| PH (1) | PH14006A (fr) |
| PT (1) | PT68522A (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2546517B1 (fr) * | 1983-05-24 | 1987-04-24 | Panmedica | Nouveaux dipeptides du -l-5-hydroxy-tryptophane, procedes pour leur preparation et medicaments les contenant |
| US5097013A (en) * | 1988-07-14 | 1992-03-17 | Kao Corporation | Novel peptides possessing a macrophage chemotactic activity |
| NZ233071A (en) * | 1989-03-30 | 1993-02-25 | Sumitomo Pharma | Neurotrophic peptides, extraction from mammalian hippocampal tissue and pharmaceutical compositions thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3864481A (en) * | 1972-12-14 | 1975-02-04 | St Lukes Hospital | Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor |
| US4113858A (en) * | 1975-01-20 | 1978-09-12 | St. Luke's Hospital | Novel compounds, compositions and methods of their use |
| FI770219A (fr) * | 1976-02-02 | 1977-08-03 | Sandoz Ag |
-
1978
- 1978-08-17 DE DE7878100685T patent/DE2860579D1/de not_active Expired
- 1978-08-17 EP EP78100685A patent/EP0001061B1/fr not_active Expired
- 1978-08-29 FI FI782641A patent/FI64798C/fi not_active IP Right Cessation
- 1978-08-29 DK DK381978A patent/DK381978A/da not_active Application Discontinuation
- 1978-09-05 AT AT0639878A patent/AT372075B/de active
- 1978-09-05 IL IL55507A patent/IL55507A/xx unknown
- 1978-09-05 IE IE1798/78A patent/IE47341B1/en unknown
- 1978-09-05 NZ NZ188345A patent/NZ188345A/xx unknown
- 1978-09-05 ES ES473071A patent/ES473071A1/es not_active Expired
- 1978-09-06 US US05/940,051 patent/US4187295A/en not_active Expired - Lifetime
- 1978-09-06 PH PH21573A patent/PH14006A/en unknown
- 1978-09-06 PT PT68522A patent/PT68522A/fr unknown
- 1978-09-07 CA CA000310850A patent/CA1118768A/fr not_active Expired
- 1978-09-07 IT IT27432/78A patent/IT1099493B/it active
- 1978-09-07 JP JP11055978A patent/JPS5448758A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA1118768A (fr) | 1982-02-23 |
| PH14006A (en) | 1980-11-28 |
| FI782641A (fi) | 1979-03-08 |
| IL55507A (en) | 1981-12-31 |
| EP0001061A1 (fr) | 1979-03-21 |
| ATA639878A (de) | 1983-01-15 |
| AT372075B (de) | 1983-08-25 |
| IE781798L (en) | 1979-03-07 |
| IT1099493B (it) | 1985-09-18 |
| JPS5448758A (en) | 1979-04-17 |
| ES473071A1 (es) | 1979-10-16 |
| DE2860579D1 (en) | 1981-04-23 |
| IE47341B1 (en) | 1984-02-22 |
| IT7827432A0 (it) | 1978-09-07 |
| PT68522A (fr) | 1978-10-01 |
| NZ188345A (en) | 1981-05-01 |
| DK381978A (da) | 1979-03-08 |
| US4187295A (en) | 1980-02-05 |
| FI64798B (fi) | 1983-09-30 |
| EP0001061B1 (fr) | 1981-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI92326C (fi) | LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina | |
| RU2180668C2 (ru) | Гептапептидные аналоги окситоцина | |
| PT81407B (en) | Process for the preparation of peptides having pharmacological activity | |
| HU185535B (en) | Process for preparing new gonadoliberin derivatives | |
| CZ297281B6 (cs) | Syntetický amid opioidního peptidu a farmaceutický prostredek | |
| US4742156A (en) | Peptide antagonists of neurokinin B and opthalmic solutions containing them | |
| CA1197235A (fr) | Analogues d'encephalines | |
| HU203563B (en) | Process for producing opioid-polypeptides and pharmaceutical compositions containing them | |
| FI82254B (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara peptider och salter daerav. | |
| HU199879B (en) | Process for producing hexapeptides and pharmaceutical compositions comprising same as active ingredient | |
| US4665157A (en) | Peptide antagonists of neurokinin B | |
| FI64798C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara polypeptider | |
| HU181843B (en) | Process for producing acth derivatives of psichopharmacological activity | |
| JPS58109460A (ja) | エンケフアリン誘導体 | |
| KR890002085B1 (ko) | 디히드로오로트산 유도체의 제조방법 | |
| Goghari et al. | Structure-activity relationships for the competitive angiotensin antagonist [sarcosine1, O-methyltyrosine4] angiotensin II (sarmesin) | |
| EP0755942B1 (fr) | Derive type n-amidino de dermorphin | |
| JPH0631314B2 (ja) | 新規なゴナドリベリン誘導体 | |
| US4476117A (en) | Dimers of peptide amides | |
| CA2405724C (fr) | Analogues de la substance p destines au traitement du cancer | |
| JPH03505734A (ja) | 非常にオピオイドレセプター選択性に優れたペプチド | |
| CA2385910A1 (fr) | Analogues de la somatostatine destines au traitement du cancer | |
| HUT63856A (en) | Process for producing peptides for treating the ageing and disorders of the immune system and central nervous system | |
| Suli-Vargha et al. | Synthesis and antitumor activity of N-terminal proline-containing peptide-(chloroethyl) nitrosoureas | |
| SE501678C2 (sv) | Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: SANDOZ AG |